ProCAncer – I and the EUCAIM project featured in the “El País Medicina”

Published on: February 28, 2023
Categories: News

An article from our partner, Gloria Ribas, Clinical Data Scientist del Grupo de Investigación Biomédica en Imagen (Instituto de Investigación Sanitaria La Fe) was published on the 25th of February in the special Medical Edition of the El País newspaper. 

The article deals with major advances in medicine, made possible by a combination of technological innovation and research developments. Genomics and various application of Artificial Intelligence or natural language processing techniques allow the transition from unstructured information to structured and organized information. This information, which until less than a decade ago was in paper format, has undergone a dizzying transformation towards digitalization in all healthcare services. To address this great challenge, numerous national and international initiatives are being carried out, such as the EUCAIM, where data and its access in a digital, massive, and secure manner is the central axis of all research. The European Union, in its recent Horizon Europe program, gives priority to funding research projects, such as the ProCAncer-I project, focused on the collection, storage and sustainable management of structured clinical data for subsequent exploitation in research projects and with the aim of contributing to personalized medicine.

Read more:

Highlights

ProCAncer-I at the EMUC24 in Lisbon

ProCAncer-I at the EMUC24 in Lisbon

The progress of major trials, the advent of artificial intelligence (AI), and interdisciplinary best practices will comprise the scientific programme of the 16th European Multidisciplinary Congress on Urological Cancers (EMUC24), which will take place from 7 to 10...

Third Dissemination Event of the ProCAncer-I Project in Athens

Third Dissemination Event of the ProCAncer-I Project in Athens

ProCAncer-I organised the 3rd Dissemination Event of the project at the 21st IEEE International Symposium on Biomedical Imaging, held in Athens, Greece, May 27-30, 2024. During the symposium, ProCAncer-I organised the Workshop “Integrating imaging Data and AI models...

AI in PCa imaging : The current status and future perspectives

AI in PCa imaging : The current status and future perspectives

Ιn recent years, magnetic resonance imaging (MRI) has transformed the prostate cancer (PCa) diagnostic pathway, based on the evidence of multiple high-level evidence studies (refs 4M, MRI first, and PROMIS). Taken together, the evidence indicates that prostate MRI...

Stay in touch!